Table 2 Biochemical parameters for all types of therapies—DPP4I study, Anuradhapura 2017
Investigation | OOH group (n = 126) | DPP4I group (n = 63) | Estimated difference of means (95% CI) | p value* | ||
|---|---|---|---|---|---|---|
Median (IQR) | Mean (SD) | Median (IQR) | Mean (SD) | |||
eGFR (ml/min/1.73m2) | 88.5 (73–101) | 88.2 (17.0) | 88 (71–98) | 85.9 (16.4) | − 2.3 (− 7.4 to 2.8) | 0.379 |
HbA1C (%) | 8.4 (7–10) | 8.8 (1.9) | 8.5 (7–10) | 8.6 (1.8) | −2.0 (−0.8 to 0.4) | 0.569 |
Pancreatic amylase (U/L) | 36 (27–48) | 44.8 (57.1) | 38 (32–55) | 47 (27.1) | 2.2 (−12.8 to 17.2) | 0.171 |
Serum lipase (U/L) | 45 (35–60) | 48.6 (18.6) | 52 (42–73) | 69.9 (67.2) | 21.3 (8.6 to 34.0) | 0.012 |
AST (U/L) | 23 (17–30) | 26.4 (18.4) | 25 (20–32) | 28.3 (15.9) | 1.9 (−3.5 to 7.3) | 0.238 |
ALT (U/L) | 22 (15–33) | 26 (15.5) | 24 (16–34) | 29.9 (19.9) | 3.9 (−1.3 to 9.1) | 0.347 |